Navigator Guided e-Psychoeducational Intervention
1 other identifier
observational
391
1 country
1
Brief Summary
The purpose of this study is to evaluate the impact of providing newly diagnosed prostate cancer patients and their caregivers with an interactive mobile tablet technology-based application delivered by a community navigator versus providing National Cancer Institute (NCI) information booklets delivered by a Community Navigator (CN) on patient outcomes (decisional satisfaction, quality of life, knowledge, decisional conflict) and shared decision making practices (decision making involvement).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 2, 2014
CompletedFirst Submitted
Initial submission to the registry
July 2, 2014
CompletedFirst Posted
Study publicly available on registry
July 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 17, 2017
CompletedAugust 22, 2017
August 1, 2017
2.6 years
July 2, 2014
August 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Final Survey Results per Study Arm
Investigators plan to assess if the psycho-educational intervention, PHIN, delivered by a CN is more efficacious as compared to NCI Information Booklets (IB) delivered by a CN. Participants will be asked to complete a baseline set of surveys and follow-up surveys at three additional time points: (1) 6 weeks after receiving the educational intervention; (2) after the follow-up decision with their doctor or health care provider; and (3) 6 months after the baseline surveys were done.
6 months post baseline survey
Study Arms (2)
PHI Navigator
Personalized Health Information Navigator (PHIN).
NCI Information Booklets (IB)
National Cancer Institute (NCI) Information Booklets (IB).
Interventions
The application (or "app") titled Personalized Health Information Navigator (PHIN) is an interactive psycho-educational intervention that will be delivered via mobile tablet technology. The PHIN provides patient-centered education. At the first meeting, the community navigator will provide a visual demonstration of PHIN on the Apple iPad. The community navigator will leave the iPad with the participant for 6-weeks and will stress the importance of using the PHIN app to address any educational or psychosocial needs.
Participants will receive a packet of information booklets ("What You Need to Know About Prostate Cancer"; "Taking Time: Support for People with Cancer"; and "Facing Forward, Life After Cancer Treatment") that address prostate cancer treatment options, the late and long term effects, follow-up care, and sources of support. At the first meeting, the community navigator will provide a review of the print materials and stress the importance of reading the booklets carefully to help prepare for the discussion with your healthcare provider. The community navigator will leave the print materials with the participant for 6-weeks.
Eligibility Criteria
Patients from Moffitt Cancer Center Genitourinary Clinic, University of South Florida Genitourinary Clinic, or community-based urologists and primary care providers.
You may qualify if:
- Men newly diagnosed (within 6 months) with biopsy confirmed case of prostate cancer
- years of age
- Able to speak and read English
- Live within 120 miles of a healthcare treatment facility
- Have no documented or observable visual, auditory, psychiatric, or neurological disorders that would interfere with study participation
- Be able to complete telephone interviews
- Have not completed the first course of treatment
- Have a family member/caregiver willing to participate
- Capable of providing written consent for study participation. Men diagnosed with early stage, locally advanced or metastatic disease or men who are on active surveillance will be eligible to participate in this study.
- Caregiver must be aged 18 or older
- Caregiver must be identified by patient as their caregiver (i.e., provider of emotional and/or physical care)
- Caregiver must have not been diagnosed with cancer in the previous year or be receiving cancer treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
H. Lee Moffitt Cancer and Research Institute
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
B. Lee Green, PhD
H. Lee Moffitt Cancer Center and Research Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2014
First Posted
July 10, 2014
Study Start
June 2, 2014
Primary Completion
December 30, 2016
Study Completion
August 17, 2017
Last Updated
August 22, 2017
Record last verified: 2017-08